XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -227.50%-163.2M | -134.82%-82.1M | -411.94%-117.6M | 14.65%396.8M | -4.6M | 128M | 235.8M | 37.7M | 179.56%346.1M | -87.18%-435M |
Net income from continuing operations | 118.49%8.3M | -937.50%-113.9M | -107.48%-44.4M | -12,442.70%-1.12B | ---49.6M | ---44.9M | --13.6M | ---21.4M | -45.90%-8.9M | 82.67%-6.1M |
Operating gains losses | 13.95%-7.4M | 700.00%600K | -66.67%100K | 25.69%-32.1M | ---2.5M | ---8.6M | ---100K | --300K | -947.06%-43.2M | -7.27%5.1M |
Depreciation and amortization | 5.29%310.3M | 28.77%511.2M | -8.41%245M | 5.58%1.82B | --511.1M | --294.7M | --397M | --267.5M | 8.07%1.73B | 92.43%1.6B |
Deferred tax | --0 | 3,150.00%6.5M | -300.00%-400K | -1,256.25%-18.5M | ---5.2M | --300K | --200K | --200K | 33.33%1.6M | -36.84%1.2M |
Other non cash items | -15.83%30.3M | 26.09%8.7M | 31.67%7.9M | -63.18%77.5M | --55.4M | --36M | --6.9M | --6M | 352.69%210.5M | 13.41%46.5M |
Change In working capital | -203.23%-526.4M | -158.97%-515.6M | -56.94%-356.4M | 9.33%-1.47B | ---589M | ---173.6M | ---199.1M | ---227.1M | 24.64%-1.62B | -89.58%-2.15B |
-Change in receivables | -21.09%-17.8M | -6.12%26.1M | 0.29%136.7M | 163.04%105.6M | --48.2M | ---14.7M | --27.8M | --136.3M | -114.47%-167.5M | -151.35%-78.1M |
-Change in payables and accrued expense | -513.33%-24.8M | -38.04%-98.7M | -53.81%-30.3M | -489.51%-181.9M | ---145.6M | --6M | ---71.5M | ---19.7M | 227.60%46.7M | 50.61%-36.6M |
-Change in other current assets | -224.14%-488.8M | -155.15%-483M | -62.67%-610.5M | 11.92%-1.42B | ---470.5M | ---150.8M | ---189.3M | ---375.3M | 17.57%-1.61B | -63.49%-1.96B |
-Change in other current liabilities | 7.52%-24.6M | -83.60%7.1M | -875.76%-64.4M | -79.03%29M | --18.5M | ---26.6M | --43.3M | ---6.6M | 288.42%138.3M | -37.45%-73.4M |
-Change in other working capital | 136.80%29.6M | 450.00%32.9M | 455.24%212.1M | 96.73%-800K | ---39.6M | --12.5M | ---9.4M | --38.2M | -410.42%-24.5M | -112.50%-4.8M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -227.50%-163.2M | -134.82%-82.1M | -411.94%-117.6M | 14.65%396.8M | ---4.6M | --128M | --235.8M | --37.7M | 179.56%346.1M | -87.18%-435M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 100.31%1M | 426.09%7.5M | -608.62%-41.1M | -1,303.83%-376.8M | -11.3M | -317.7M | -2.3M | -5.8M | 117.32%31.3M | -60,133.33%-180.7M |
Capital expenditure reported | 18.75%-1.3M | -114.29%-4.5M | -192.86%-4.1M | -433.85%-34.7M | ---10M | ---1.6M | ---2.1M | ---1.4M | -6.56%-6.5M | 40.20%-6.1M |
Net business purchase and sale | --0 | 206.19%12M | ---2M | -1,277.78%-339.2M | ---2M | ---331.1M | ---11.3M | --0 | 330.40%28.8M | -355.10%-12.5M |
Net investment purchase and sale | -70.00%1.5M | ---- | ---- | ---- | ---- | --5M | ---- | ---- | ---- | ---- |
Net other investing changes | -92.00%800K | --0 | -695.45%-35M | -152.11%-3.7M | ---100K | --10M | --10.9M | ---4.4M | 104.19%7.1M | -3,486.00%-169.3M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 100.31%1M | 426.09%7.5M | -608.62%-41.1M | -1,303.83%-376.8M | ---11.3M | ---317.7M | ---2.3M | ---5.8M | 117.32%31.3M | -60,133.33%-180.7M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -48.64%137.6M | 139.92%125.9M | 137.57%41.1M | 110.04%39.6M | 57M | 267.9M | -315.4M | 17.3M | -175.07%-394.5M | 43.97%525.5M |
Net issuance payments of debt | -56.21%146M | 142.65%167.1M | -202.40%-161.9M | -34.04%267.4M | --252M | --333.4M | ---391.8M | --158.1M | -39.96%405.4M | 145.97%675.2M |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | --500K | --0 | ---- | ---- | ---- | ---- | ---- |
Net other financing activities | 87.18%-8.4M | -153.93%-41.2M | 244.18%203M | 71.46%-228.3M | ---195M | ---65.5M | --76.4M | ---140.8M | -434.34%-799.9M | -265.41%-149.7M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -48.64%137.6M | 139.92%125.9M | 137.57%41.1M | 110.04%39.6M | --57M | --267.9M | ---315.4M | --17.3M | -175.07%-394.5M | 43.97%525.5M |
Net cash flow | ||||||||||
Beginning cash position | 23.87%270.4M | -27.75%216.6M | 33.02%334.4M | 15.80%313M | --333.2M | --218.3M | --299.8M | --251.4M | -25.19%270.3M | 60.72%361.3M |
Current changes in cash | -131.46%-24.6M | 162.64%51.3M | -339.02%-117.6M | 448.54%59.6M | --41.1M | --78.2M | ---81.9M | --49.2M | 81.04%-17.1M | -168.18%-90.2M |
Effect of exchange rate changes | -766.67%-6M | 525.00%2.5M | 75.00%-200K | 33.33%-1.2M | ---2.9M | --900K | --400K | ---800K | -125.00%-1.8M | -119.05%-800K |
End cash Position | -19.37%239.8M | 23.87%270.4M | -27.75%216.6M | 47.73%371.4M | --371.4M | --297.4M | --218.3M | --299.8M | -6.99%251.4M | -25.19%270.3M |
Free cash flow | -230.14%-164.5M | -137.06%-86.6M | -435.26%-121.7M | 6.63%362.1M | ---14.6M | --126.4M | --233.7M | --36.3M | 176.99%339.6M | -81.82%-441.1M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |